DE69906558T2 - Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität - Google Patents

Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität Download PDF

Info

Publication number
DE69906558T2
DE69906558T2 DE69906558T DE69906558T DE69906558T2 DE 69906558 T2 DE69906558 T2 DE 69906558T2 DE 69906558 T DE69906558 T DE 69906558T DE 69906558 T DE69906558 T DE 69906558T DE 69906558 T2 DE69906558 T2 DE 69906558T2
Authority
DE
Germany
Prior art keywords
group
hydroxy
compounds
use according
chlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69906558T
Other languages
German (de)
English (en)
Other versions
DE69906558D1 (de
Inventor
Charles Advenier
Luciano Manara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69906558D1 publication Critical patent/DE69906558D1/de
Application granted granted Critical
Publication of DE69906558T2 publication Critical patent/DE69906558T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DE69906558T 1998-10-14 1999-09-29 Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität Expired - Lifetime DE69906558T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9812877 1998-10-14
FR9812877A FR2784582B3 (fr) 1998-10-14 1998-10-14 Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste
PCT/FR1999/002308 WO2000021508A2 (fr) 1998-10-14 1999-09-29 Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste

Publications (2)

Publication Number Publication Date
DE69906558D1 DE69906558D1 (de) 2003-05-08
DE69906558T2 true DE69906558T2 (de) 2004-02-26

Family

ID=9531553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906558T Expired - Lifetime DE69906558T2 (de) 1998-10-14 1999-09-29 Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität

Country Status (11)

Country Link
US (1) US6310050B1 (fr)
EP (1) EP1121108B1 (fr)
JP (1) JP2002527377A (fr)
AT (1) ATE235899T1 (fr)
AU (1) AU5868699A (fr)
DE (1) DE69906558T2 (fr)
DK (1) DK1121108T3 (fr)
ES (1) ES2195612T3 (fr)
FR (1) FR2784582B3 (fr)
PT (1) PT1121108E (fr)
WO (1) WO2000021508A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
EP1514869A1 (fr) * 2002-06-12 2005-03-16 Sumitomo Pharmaceuticals Company, Limited Indole, indazole, et derive benzazole
EP2999461B1 (fr) * 2013-05-23 2020-03-11 The University of Newcastle Administration ciblée de médicaments dans le myométrium
US20170065589A1 (en) 2014-05-06 2017-03-09 Anthony G. Visco Methods of treating or preventing preterm labor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65511B1 (en) * 1989-12-29 1995-11-01 Sanofi Sa New phenylethanolaminomethyltetralins
EP0627407A1 (fr) 1993-05-28 1994-12-07 MIDY S.p.A. Acide (7S)-7-[(2R)-2(3-chlorophényl)-2-hydroxyéthylamino]-5,6,7,8-tétrahydronaphtalèn-2-yloxy acétique, ses sels pharmaceutiquement acceptables, à action agoniste bêta-3 adrénergique et compositions pharmaceutiques le contenant

Also Published As

Publication number Publication date
DE69906558D1 (de) 2003-05-08
AU5868699A (en) 2000-05-01
WO2000021508A3 (fr) 2000-10-26
US6310050B1 (en) 2001-10-30
FR2784582B3 (fr) 2000-11-24
PT1121108E (pt) 2003-08-29
JP2002527377A (ja) 2002-08-27
ES2195612T3 (es) 2003-12-01
EP1121108A2 (fr) 2001-08-08
DK1121108T3 (da) 2003-07-21
EP1121108B1 (fr) 2003-04-02
FR2784582A1 (fr) 2000-04-21
ATE235899T1 (de) 2003-04-15
WO2000021508A2 (fr) 2000-04-20

Similar Documents

Publication Publication Date Title
DE69415535T2 (de) Verfahren zur regulierung der sexuellen reaktion beim menschen
DE602005005165T2 (de) Verfahren zur verbesserung der bioverfügbarkeit von ospemifen
DE69819748T2 (de) Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
DE69511566T2 (de) Triphenylethylene zur vorbeugung und behandlung von osteoporose
DE69010336T2 (de) Pharmazeutische zusammensetzung zum abnehmen.
DE68907406T2 (de) Deprenyl zur systemischen transdermalen anwendung.
DE60217324T2 (de) Pharmazeutische zusammensetzung für die hormonersatztherapie
DE69534693T2 (de) Sublinguale Zusammensetzung enthaltend Apomorphine zur Diagnose der funktionellen Impotenz
DE69735552T2 (de) Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
DE3235093A1 (de) Antiparkinsonmittel
DE69133341T2 (de) Zusammensetzungen und behandlungsverfahren für sympathisch unterhaltenen schmerz
JP2008189685A (ja) 頻尿および尿失禁の予防・治療剤
DE3805744C2 (de) Phenylcarbamate zur Hemmung der Acetylcholinesterase
CA2431795A1 (fr) Administration topique ou orale d'une composition contenant du pelargonium malodorant pour le diagnostic et le traitement de diverses nevralgies et d'autres troubles
DE69911755T2 (de) Synthetische endogene cannabinoidanaloge und ihre verwendungen
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE69906558T2 (de) Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität
DE69408294T2 (de) Pharmazeutische Zusammensetzung enthaltend Diphenhydramin, Talc, Zinkoxid und Haferextrakt in Emulsionsträger, sowie deren Verwendung
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
EP0629405A1 (fr) Agent pour inhiber la dimination de la substanze osseuren en osteodystrophierenale
DE60309465T2 (de) Verfahren zur Hemmung oder Vorbeugung von urogenitaler Atrophie und deren Symptome bei Frauen
DE69626312T2 (de) Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis
EP1397128B1 (fr) Agoniste opiace de type kappa pour le traitement de la vessie irritable
EP1063998B1 (fr) Medicament contenant un inhibiteur steroidien de l'aromatase pour la prophylaxie et/ou le traitement du carcinome du sein
DE69620786T2 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

R082 Change of representative

Ref document number: 1121108

Country of ref document: EP

Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE